Antihypertensive treatment will cause cancers of the skin
Published the 06.12.2017 at 0725 hrs
HTAhydrochlorothiazidecancer of the skin
Once again, the Danish researchers have set their sights on antihypertensive drugs contain hydrochlorothiazide to mount that they would be involved in the increased risk of cancer of the skin.
The researchers have already shown that this diuretic, which is one of the most commonly used in the world, may increase the risk of cancer of the lips, which is of the same type as squamous cell cancers of the skin.
In this new study, doctors have identified a clear link between the use of hydrochlorothiazide and the possibility of developing cancer squamous cell of the skin.
Risk is surprisingly high
“We knew that hydrochlorothiazide made the skin more vulnerable to damage caused by the UV rays of the sun,” acknowledges Anton Pottegård, the initiator of the study. “But what is new and surprising is that the long-term use of this drug leads to a significant increase in the risk of cancer of the skin “.
There are several types of skin cancer, and squamous cell carcinoma, in which the hydrochlorothiazide is now associated, generates a rate of mortality very low.
The need of protection against UV rays
However, these cancers of the lips and of the skin are usually treated by a surgical operation which may cause a certain risk of complications and a low risk, but real, that the cancer is squamous cell skin spreads.
The research team has initiated a dialogue with the medical societies concerned as well as with the Danish Agency of medicines about their work.
If you are hypertensive and treated with hydrochlorothiazide, and that you love the sun, it’s time to buy the total screen.